Personal information

No personal information available

Activities

Collapse all

Works (14)

Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells

Biomolecules
2024-11 | Journal article | Author
DOI: 10.3390/biom14111407
Contributors: Haoying Yang; Bolei Dai; Liangjie Chen; Yingping Li; Xiaorui Jin; Chengchang Gao; Linfen Han; Xueli Bian
Source: check_circle
Multidisciplinary Digital Publishing Institute

MDH2 Promotes Hepatocellular Carcinoma Growth Through Ferroptosis Evasion via Stabilizing GPX4

International Journal of Molecular Sciences
2024-10 | Journal article | Author
DOI: 10.3390/ijms252111604
Contributors: Wenjia Yu; Yingping Li; Chengchang Gao; Donglin Li; Liangjie Chen; Bolei Dai; Haoying Yang; Linfen Han; Qinqin Deng; Xueli Bian
Source: check_circle
Multidisciplinary Digital Publishing Institute

Natural Product Auraptene Targets SLC7A11 for Degradation and Induces Hepatocellular Carcinoma Ferroptosis

Antioxidants
2024-08 | Journal article | Author
DOI: 10.3390/antiox13081015
Contributors: Donglin Li; Yingping Li; Liangjie Chen; Chengchang Gao; Bolei Dai; Wenjia Yu; Haoying Yang; Junxiang Pi; Xueli Bian
Source: check_circle
Multidisciplinary Digital Publishing Institute

Regulation of gene expression by glycolytic and gluconeogenic enzymes

Trends in Cell Biology
2022-09 | Journal article
DOI: 10.1016/j.tcb.2022.02.003
Part of ISSN: 0962-8924
Contributors: Xueli Bian
Source: Self-asserted source
Xueli Bian

Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets

Molecular Cell
2021-07 | Journal article
DOI: 10.1016/j.molcel.2021.05.005
Part of ISSN: 1097-2765
Source: Self-asserted source
Xueli Bian

Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma.

Frontiers in oncology
2021-03-26 | Journal article
DOI: 10.3389/fonc.2021.561247
PMID: 33842305
PMC: PMC8033018
Source: Self-asserted source
Xueli Bian

The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies.

Cell metabolism
2021-01-05 | Journal article
DOI: 10.1016/j.cmet.2020.12.015
PMID: 33406403
Source: Self-asserted source
Xueli Bian

Lipid metabolism and cancer

Journal of Experimental Medicine
2021-01-04 | Journal article
DOI: 10.1084/jem.20201606
Part of ISSN: 0022-1007
Part of ISSN: 1540-9538
Source: Self-asserted source
Xueli Bian

Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma.

European journal of cancer (Oxford, England : 1990)
2020-12-02 | Journal article
DOI: 10.1016/j.ejca.2020.09.040
PMID: 33278777
Source: Self-asserted source
Xueli Bian
grade
Preferred source (of 2)‎

Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment

Molecular Cell
2020-05-28 | Journal article
DOI: 10.1016/j.molcel.2020.05.004
ISSN: 1097-2765
Source: Self-asserted source
Xueli Bian

Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation

Nature Communications
2017-02-27 | Journal article
DOI: 10.1038/ncomms14420
Part of ISSN: 2041-1723
Source: Self-asserted source
Xueli Bian

Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity

Chemistry & Biology
2015-08 | Journal article
DOI: 10.1016/j.chembiol.2015.06.023
Part of ISSN: 1074-5521
Source: Self-asserted source
Xueli Bian

Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway

Nature Chemical Biology
2014-02 | Journal article
DOI: 10.1038/nchembio.1406
Part of ISSN: 1552-4450
Part of ISSN: 1552-4469
Source: Self-asserted source
Xueli Bian

MDH2 Promotes Hepatocellular Carcinoma Growth through Ferroptosis Evasion via Stabilizing GPX4
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (3 reviews for 1 publication/grant)

Review activity for Heliyon. (3)
How many people are using ORCID?